Heron Therapeutics, Inc. /De/
2019 Q4 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 63 | 0.0% | 48,659 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 499 | 0.0% | 241,048 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 505 | 0.0% | 229,332 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 68 | 0.0% | 44,285 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 89 | 0.0% | 44,512 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 160 | 0.0% | 45,771 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 109 | 0.0% | 39,443 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 70 | 0.0% | 40,921 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 20 | 0.0% | 19,603 | 9/30/2023 |
| 2023 Q1 | 5/15/2023 | 63 | 0.0% | 41,756 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 104 | 0.0% | 41,756 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 177 | 0.0% | 41,887 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 120 | 0.0% | 43,149 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 227 | 0.0% | 39,600 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 448 | 0.0% | 49,117 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 523 | 0.0% | 48,936 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 813 | 0.0% | 52,415 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 795 | 0.0% | 49,038 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,088 | 0.0% | 51,408 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 734 | 0.0% | 49,509 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 719 | 0.0% | 50,446 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 604 | 0.0% | 51,462 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,001 | 0.0% | 42,592 | 12/31/2019 |